Compounds > methyldopa
Page last updated: 2024-08-23

methyldopa and Puerperal Disorders

methyldopa has been researched along with Puerperal Disorders in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19905 (71.43)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borrajo Prol, MP; Bravo López, JJ; Iglesias Forneiro, A; Santos Nores, J1
De Swiet, M; Fidler, J; Smith, V1
De Andrade, J1
Aber, VR; De Vries, LS; Derham, RJ; Elder, MG; Hawkins, DF1
Griffis, KR; Martin, JN; Martin, RW; Morrison, JC; Palmer, SM1
Almog, S; Hauser, GJ; Spirer, Z; Tirosh, M1
Luke, RG1

Trials

2 trial(s) available for methyldopa and Puerperal Disorders

ArticleYear
A randomized study comparing timolol and methyldopa in hospital treatment of puerperal hypertension.
    British journal of obstetrics and gynaecology, 1982, Volume: 89, Issue:12

    Topics: Adult; Female; Humans; Hypertension; Methyldopa; Pregnancy; Propanolamines; Puerperal Disorders; Random Allocation; Timolol

1982
Utilization of hydralazine or alpha-methyldopa for the management of early puerperal hypertension.
    American journal of perinatology, 1989, Volume: 6, Issue:4

    Topics: Blood Pressure; Fees, Pharmaceutical; Female; Humans; Hydralazine; Hypertension; Magnesium Sulfate; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Random Allocation

1989

Other Studies

5 other study(ies) available for methyldopa and Puerperal Disorders

ArticleYear
[HTA-pre-eclampsia-postpartum haemolytic-uraemic syndrome: good results can be achieved].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2010, Volume: 30, Issue:5

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents; Antihypertensive Agents; Cesarean Section; Combined Modality Therapy; Emergencies; Female; Hemolytic-Uremic Syndrome; Humans; Hypertension; Labetalol; Methyldopa; Plasmapheresis; Pre-Eclampsia; Prednisone; Pregnancy; Puerperal Disorders; Remission Induction

2010
[Use of alphamethyldopa during the pregnancy-puerperium cycle in hypertensive patients and evaluation of their offspring up to their 3rd year of life].
    Arquivos brasileiros de cardiologia, 1990, Volume: 55, Issue:2

    Topics: Adult; Birth Weight; Blood Pressure; Child, Preschool; Female; Humans; Hypertension; Infant; Infant, Newborn; Male; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Puerperal Disorders

1990
Outcome of pregnancies complicated by severe hypertension and delivered before 34 weeks; stepwise logistic regression analysis of prognostic factors.
    British journal of obstetrics and gynaecology, 1989, Volume: 96, Issue:10

    Topics: Adult; Birth Weight; Cerebral Hemorrhage; Cesarean Section; Female; Fetal Growth Retardation; Gestational Age; Humans; Hydralazine; Hypertension; Infant, Newborn; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Prognosis; Proteinuria; Puerperal Disorders; Regression Analysis

1989
Effect of alpha-methyldopa excreted in human milk on the breast-fed infant.
    Helvetica paediatrica acta, 1985, Volume: 40, Issue:1

    Topics: Adult; Breast Feeding; Female; Humans; Hypertension; Infant, Newborn; Kinetics; Methyldopa; Milk, Human; Pregnancy; Puerperal Disorders

1985
Heparin treatment for post-partum renal failure with microangiopathic haemolytic anaemia.
    Lancet (London, England), 1971, Apr-17, Volume: 1, Issue:7703

    Topics: Acute Kidney Injury; Adult; Anemia, Hemolytic; Female; Heparin; Humans; Methyldopa; Pregnancy; Puerperal Disorders

1971